Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 4987-4991, November 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, R. B.
Right arrow Articles by Anderson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, R. B.
Right arrow Articles by Anderson, E.

Dissociation between Steroid Receptor Expression and Cell Proliferation in the Human Breast1

Robert B. Clarke2, Anthony Howell, Christopher S. Potten and Elizabeth Anderson

Tumor Biochemistry Laboratory, Clinical Research Department [R. B. C., E. A.], Department of Epithelial Biology, Paterson Institute for Cancer Research [C. S. P.], and Cancer Research Campaign Department of Medical Oncology [A. H.], (University of Manchester) Christie Hospital (National Health Service) Trust, Manchester M20 4BX, United Kingdom

We have shown previously that estradiol stimulates cell proliferation and progesterone receptor (PgR) synthesis in luminal epithelial cells of the normal human breast. Approximately 10–15% of luminal epithelial cells within the normal breast express immunodetectable estrogen receptor (ER), but little is known about their distribution within lobules and their organization in relation to the smaller population of proliferating cells. Using normal human breast tissue, we show that ER-positive cells are distributed evenly throughout the mammary epithelium. Using double antibody immunofluorescence, we show that 96% of steroid receptor-positive cells synthesize both ER and PgR (n = 25). Double labeling with antibodies to either ER or PgR coupled with either [3H]thymidine histoautoradiography or with antibodies to the Ki67 proliferation antigen indicates that dividing cells are separate from those expressing the receptors (although they are often in close proximity). However, in contrast to the normal human breast, two-thirds of ER-positive human mammary tumors examined (n = 19) have a high proportion of dividing cells that are ER positive. These data are consistent with the hypothesis that cells in normal human breast epithelium are hierarchical in organization and support a model in which proliferation of ER-negative cells is controlled by paracrine factors released from ER-positive cells under the influence of estradiol. This organization may be disrupted in some tumors.

1 R. B. C. and E. A. are supported by the Christie Hospital (National Health Service) Trust Research Endowment Fund. A. H. and C. S. P. are supported by the Cancer Research Campaign.

2 To whom requests for reprints should be addressed, at Tumor Biochemistry Laboratory, Clinical Research Department, Christie Hospital-Paterson Institute, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom. Phone: 0161-446-3210; Fax: 0161-446-3218; E-mail: clrrbc@picr.cr.man.ac.uk.

Received 8/18/97. Accepted 10/ 3/97.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Otto, I. Fuchs, H. Altmann, M. Klewer, A. Walter, K. Prelle, R. Vonk, and K.-H. Fritzemeier
Comparative Analysis of the Uterine and Mammary Gland Effects of Drospirenone and Medroxyprogesterone Acetate
Endocrinology, August 1, 2008; 149(8): 3952 - 3959.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Rizzo, H. Miao, G. D'Souza, C. Osipo, J. Yun, H. Zhao, J. Mascarenhas, D. Wyatt, G. Antico, L. Hao, et al.
Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches
Cancer Res., July 1, 2008; 68(13): 5226 - 5235.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M A Thorat, C Marchio, A Morimiya, K Savage, H Nakshatri, J S Reis-Filho, and S Badve
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
J. Clin. Pathol., March 1, 2008; 61(3): 327 - 332.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
K. Britt, A. Ashworth, and M. Smalley
Pregnancy and the risk of breast cancer
Endocr. Relat. Cancer, December 1, 2007; 14(4): 907 - 933.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Hiremath, J. P. Lydon, and P. Cowin
The pattern of {beta}-catenin responsiveness within the mammary gland is regulated by progesterone receptor
Development, October 15, 2007; 134(20): 3703 - 3712.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. E. Wood, J. M. Hester, and J. M. Cline
Mammary Gland Development in Early Pubertal Female Macaques
Toxicol Pathol, October 1, 2007; 35(6): 793 - 803.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. McGowan, A. J. Russell, V. Boonyaratanakornkit, D. N. Saunders, G. M. Lehrbach, C. M. Sergio, E. A. Musgrove, D. P. Edwards, and R. L. Sutherland
Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor
Cancer Res., September 15, 2007; 67(18): 8942 - 8951.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Badve, D. Turbin, M. A. Thorat, A. Morimiya, T. O. Nielsen, C. M. Perou, S. Dunn, D. G. Huntsman, and H. Nakshatri
FOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and Survival
Clin. Cancer Res., August 1, 2007; 13(15): 4415 - 4421.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Ishida, W. Takahashi, S. Itoh, S. Shimodaira, S. Maeda, and J. Arita
Estrogen Actions on Lactotroph Proliferation Are Independent of a Paracrine Interaction with Other Pituitary Cell Types: A Study Using Lactotroph-Enriched Cells
Endocrinology, July 1, 2007; 148(7): 3131 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
E. E. Connor, M. J. Meyer, R. W. Li, M. E. Van Amburgh, Y. R. Boisclair, and A. V. Capuco
Regulation of Gene Expression in the Bovine Mammary Gland by Ovarian Steroids
J Dairy Sci, June 1, 2007; 90(13_suppl): E55 - E65.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. Farnie, R. B. Clarke, K. Spence, N. Pinnock, K. Brennan, N. G. Anderson, and N. J. Bundred
Novel Cell Culture Technique for Primary Ductal Carcinoma In Situ: Role of Notch and Epidermal Growth Factor Receptor Signaling Pathways
J Natl Cancer Inst, April 18, 2007; 99(8): 616 - 627.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Ciarloni, S. Mallepell, and C. Brisken
Amphiregulin is an essential mediator of estrogen receptor {alpha} function in mammary gland development
PNAS, March 27, 2007; 104(13): 5455 - 5460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Rieber, M. Strasberg-Rieber, A. J. Maniotis, and R. Folberg
Different Chromatin Organization in Benign and Malignant Cells Revealed by Unequal Nuclease Sensitivity between Tumor and Normal Cell Genomes
Am. J. Pathol., February 1, 2007; 170(2): 787 - 789.
[Full Text] [PDF]


Home page
J. Cell Biol.Home page
K. E. Sleeman, H. Kendrick, D. Robertson, C. M. Isacke, A. Ashworth, and M. J. Smalley
Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland
J. Cell Biol., January 1, 2007; 176(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Shyamala, Y.-C. Chou, R. D. Cardiff, and E. Vargis
Effect of c-neu/ ErbB2 Expression Levels on Estrogen Receptor {alpha}-Dependent Proliferation in Mammary Epithelial Cells: Implications for Breast Cancer Biology
Cancer Res., November 1, 2006; 66(21): 10391 - 10398.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Mukherjee, S. M. Soyal, R. Fernandez-Valdivia, M. Gehin, P. Chambon, F. J. DeMayo, J. P. Lydon, and B. W. O'Malley
Steroid Receptor Coactivator 2 Is Critical for Progesterone-Dependent Uterine Function and Mammary Morphogenesis in the Mouse.
Mol. Cell. Biol., September 1, 2006; 26(17): 6571 - 6583.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Madureira, R. Varshochi, D. Constantinidou, R. E. Francis, R. C. Coombes, K.-M. Yao, and E. W.-F. Lam
The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor {alpha} in Breast Cancer Cells
J. Biol. Chem., September 1, 2006; 281(35): 25167 - 25176.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Poola, B. Shokrani, R. Bhatnagar, R. L. DeWitty, Q. Yue, and G. Bonney
Expression of Carcinoembryonic Antigen Cell Adhesion Molecule 6 Oncoprotein in Atypical Ductal Hyperplastic Tissues Is Associated with the Development of Invasive Breast Cancer
Clin. Cancer Res., August 1, 2006; 12(15): 4773 - 4783.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff
The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Li, F. Sotgia, M. A. Vuolo, M. Li, W. C. Yang, R. G. Pestell, J. A. Sparano, and M. P. Lisanti
Caveolin-1 Mutations in Human Breast Cancer: Functional Association with Estrogen Receptor {alpha}-Positive Status
Am. J. Pathol., June 1, 2006; 168(6): 1998 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Mallepell, A.ée Krust, P. Chambon, and C. Brisken
Paracrine signaling through the epithelial estrogen receptor {alpha} is required for proliferation and morphogenesis in the mammary gland
PNAS, February 14, 2006; 103(7): 2196 - 2201.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. M. Fowler, N. M. Solodin, C. C. Valley, and E. T. Alarid
Altered Target Gene Regulation Controlled by Estrogen Receptor-{alpha} Concentration
Mol. Endocrinol., February 1, 2006; 20(2): 291 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Grimm, A. Contreras, M.-H. Barcellos-Hoff, and J. M. Rosen
Cell Cycle Defects Contribute to a Block in Hormone-induced Mammary Gland Proliferation in CCAAT/Enhancer-binding Protein (C/EBP{beta})-null Mice
J. Biol. Chem., October 28, 2005; 280(43): 36301 - 36309.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Urruticoechea, I. E. Smith, and M. Dowsett
Proliferation Marker Ki-67 in Early Breast Cancer
J. Clin. Oncol., October 1, 2005; 23(28): 7212 - 7220.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S A Khan, D Bhandare, and R T Chatterton Jr
The local hormonal environment and related biomarkers in the normal breast
Endocr. Relat. Cancer, September 1, 2005; 12(3): 497 - 510.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. B.R. Ewan, H. A. Oketch-Rabah, S. A. Ravani, G. Shyamala, H. L. Moses, and M. H. Barcellos-Hoff
Proliferation of Estrogen Receptor-{alpha}-Positive Mammary Epithelial Cells Is Restrained by Transforming Growth Factor-{beta}1 in Adult Mice
Am. J. Pathol., August 1, 2005; 167(2): 409 - 417.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C J Fabian, B F Kimler, M S Mayo, and S A Khan
Breast-tissue sampling for risk assessment and prevention
Endocr. Relat. Cancer, June 1, 2005; 12(2): 185 - 213.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L C Murphy, B Peng, A Lewis, J R Davie, E Leygue, A Kemp, K Ung, M Vendetti, and R Shiu
Inducible upregulation of oestrogen receptor-{beta}1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
J. Mol. Endocrinol., April 1, 2005; 34(2): 553 - 566.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine
Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Carcinogenesis, April 1, 2005; 26(4): 763 - 769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Muller-Decker, I. Berger, K. Ackermann, V. Ehemann, S. Zoubova, S. Aulmann, W. Pyerin, and G. Furstenberger
Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2
Am. J. Pathol., February 1, 2005; 166(2): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Cheng, Y. Li, Y. Omoto, Y. Wang, T. Berg, M. Nord, P. Vihko, M. Warner, Y.-S. Piao, and J.-A. Gustafsson
Differential Regulation of Estrogen Receptor (ER){alpha} and ER{beta} in Primate Mammary Gland
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 435 - 444.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Fan, H. Nakshatri, and K. P. Nephew
Inhibiting Proteasomal Proteolysis Sustains Estrogen Receptor-{alpha} Activation
Mol. Endocrinol., November 1, 2004; 18(11): 2603 - 2615.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. O. Oduwole, Y. Li, V. V. Isomaa, A. Mantyniemi, A. E. Pulkka, Y. Soini, and P. T. Vihko
17{beta}-Hydroxysteroid Dehydrogenase Type 1 Is an Independent Prognostic Marker in Breast Cancer
Cancer Res., October 15, 2004; 64(20): 7604 - 7609.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Guo and G. E. Sonenshein
Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
Mol. Cell. Biol., October 1, 2004; 24(19): 8681 - 8690.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Mulac-Jericevic and O. M Conneely
Reproductive tissue selective actions of progesterone receptors
Reproduction, August 1, 2004; 128(2): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. A. King, M. L. Gemignani, W. Li, D. D. Giri, K. S. Panageas, F. Bogomolniy, C. Arroyo, N. Olvera, M. E. Robson, K. Offit, et al.
Increased Progesterone Receptor Expression in Benign Epithelium of BRCA1-Related Breast Cancers
Cancer Res., August 1, 2004; 64(15): 5051 - 5053.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. N. Holloway, S. Murthy, and D. El-Ashry
A Cytoplasmic Substrate of Mitogen-Activated Protein Kinase Is Responsible for Estrogen Receptor-{alpha} Down-Regulation in Breast Cancer Cells: The Role of Nuclear Factor-{kappa}B
Mol. Endocrinol., June 1, 2004; 18(6): 1396 - 1410.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.-A. Gustafsson, G. Khan, and L. Hilakivi-Clarke
Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis
Carcinogenesis, May 1, 2004; 25(5): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Cheng, Z. Weihua, M. Warner, and J.-A. Gustafsson
Inaugural Article: Estrogen receptors ER{alpha} and ER{beta} in proliferation in the rodent mammary gland
PNAS, March 16, 2004; 101(11): 3739 - 3746.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. D. Foulkes, K. Metcalfe, P. Sun, W. M. Hanna, H. T. Lynch, P. Ghadirian, N. Tung, O. I. Olopade, B. L. Weber, J. McLennan, et al.
Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer: The Influence of Age, Grade, and Histological Type
Clin. Cancer Res., March 15, 2004; 10(6): 2029 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Mehrotra, M. M. Ganpat, Y. Kanaan, M. J. Fackler, M. McVeigh, J. Lahti-Domenici, K. Polyak, P. Argani, T. Naab, E. Garrett, et al.
Estrogen Receptor/Progesterone Receptor-Negative Breast Cancers of Young African-American Women Have a Higher Frequency of Methylation of Multiple Genes than Those of Caucasian Women1
Clin. Cancer Res., March 15, 2004; 10(6): 2052 - 2057.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
W D Foulkes
BRCA1 functions as a breast stem cell regulator
J. Med. Genet., January 1, 2004; 41(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Elkin, I. Cohen, E. Zcharia, A. Orgel, Z. Guatta-Rangini, T. Peretz, I. Vlodavsky, and H. K. Kleinman
Regulation of Heparanase Gene Expression by Estrogen in Breast Cancer
Cancer Res., December 15, 2003; 63(24): 8821 - 8826.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. M. Wittmann, N. Wang, and M. M. Montano
Identification of a Novel Inhibitor of Breast Cell Growth That Is Down-Regulated by Estrogens and Decreased in Breast Tumors
Cancer Res., August 15, 2003; 63(16): 5151 - 5158.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
E. A. Kritikou, A. Sharkey, K. Abell, P. J. Came, E. Anderson, R. W. E. Clarkson, and C. J. Watson
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland
Development, August 1, 2003; 130(15): 3459 - 3468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, K. Miyoshi, L. Hennighausen, C. J. Ormandy, A. V. Lee, et al.
Disruption of Steroid and Prolactin Receptor Patterning in the Mammary Gland Correlates with a Block in Lobuloalveolar Development
Mol. Endocrinol., December 1, 2002; 16(12): 2675 - 2691.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. M. Ismail, J. Li, F. J. DeMayo, B. W. O'Malley, and J. P. Lydon
A Novel LacZ Reporter Mouse Reveals Complex Regulation of the Progesterone Receptor Promoter During Mammary Gland Development
Mol. Endocrinol., November 1, 2002; 16(11): 2475 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Kennedy, K. Byth, C. L. Clarke, and A. deFazio
Cell Proliferation in the Normal Mouse Mammary Gland and Inhibition by Phenylbutyrate
Mol. Cancer Ther., October 1, 2002; 1(12): 1025 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Seth, D. Porter, J. Lahti-Domenici, Y. Geng, A. Richardson, and K. Polyak
Cellular and Molecular Targets of Estrogen in Normal Human Breast Tissue
Cancer Res., August 15, 2002; 62(16): 4540 - 4544.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Adeyinka, Y. Nui, T. Cherlet, L. Snell, P. H. Watson, and L. C. Murphy
Activated Mitogen-activated Protein Kinase Expression during Human Breast Tumorigenesis and Breast Cancer Progression
Clin. Cancer Res., June 1, 2002; 8(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. B. Ewan, G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff
Latent Transforming Growth Factor-{beta} Activation in Mammary Gland : Regulation by Ovarian Hormones Affects Ductal and Alveolar Proliferation
Am. J. Pathol., June 1, 2002; 160(6): 2081 - 2093.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. R. Lakhani, M. J. van de Vijver, J. Jacquemier, T. J. Anderson, P. P. Osin, L. McGuffog, and D. F. Easton
The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2
J. Clin. Oncol., May 1, 2002; 20(9): 2310 - 2318.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
V Speirs, G P Skliris, S E Burdall, and P J Carder
Distinct expression patterns of ER{alpha} and ER{beta} in normal human mammary gland
J. Clin. Pathol., May 1, 2002; 55(5): 371 - 374.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
B. A. Stoll
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications
Ann. Onc., February 20, 2002; 13(2): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Shaaban, J. P. Sloane, C. R. West, and C. S. Foster
Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-{alpha} and Ki-67 Expression
Am. J. Pathol., February 1, 2002; 160(2): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
O. M. Conneely, B. Mulac-Jericevic, F. DeMayo, J. P. Lydon, and B. W. O'Malley
Reproductive Functions of Progesterone Receptors
Recent Prog. Horm. Res., January 1, 2002; 57(1): 339 - 355.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. V. Jensen, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes, and J.-A. Gustafsson
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
PNAS, November 29, 2001; (2001) 211556298.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson
Mechanisms of Estrogen Action
Physiol Rev, October 1, 2001; 81(4): 1535 - 1565.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Devanesan, R. J. Santen, W. P. Bocchinfuso, K. S. Korach, E. G. Rogan, and E. Cavalieri
Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-{alpha} knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors
Carcinogenesis, September 1, 2001; 22(9): 1573 - 1576.
[Abstract] [Full Text] [PDF]